Shares of Vitamin Shoppe Inc. (NYSE:VSI) have been given a consensus recommendation of “Hold” by the fourteen ratings firms that are covering the firm. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $30.89.

A number of research firms have issued reports on VSI. Jefferies Group reiterated a “hold” rating on shares of Vitamin Shoppe in a report on Thursday, August 4th. Wedbush reiterated an “outperform” rating and set a $39.00 target price on shares of Vitamin Shoppe in a report on Wednesday, August 3rd. Zacks Investment Research cut Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Wednesday, August 3rd. Morgan Stanley downgraded shares of Vitamin Shoppe from an “overweight” rating to an “equal weight” rating and reduced their price objective for the stock from $32.00 to $26.00 in a research note on Thursday, November 3rd. Finally, Barclays PLC started coverage on shares of Vitamin Shoppe in a research note on Thursday, September 22nd. They set an “equal weight” rating and a $29.00 price objective for the company.

In other Vitamin Shoppe news, CAO Dan Lamadrid sold 1,734 shares of the firm’s stock in a transaction that occurred on Tuesday, November 8th. The shares were sold at an average price of $23.20, for a total transaction of $40,228.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.29% of the company’s stock.

A number of large investors have recently modified their holdings of the company. Dimensional Fund Advisors LP increased its stake in shares of Vitamin Shoppe by 22.4% in the second quarter. Dimensional Fund Advisors LP now owns 2,047,529 shares of the company’s stock valued at $62,593,000 after buying an additional 374,360 shares during the period. Eagle Asset Management Inc. increased its stake in shares of Vitamin Shoppe by 13.8% in the third quarter. Eagle Asset Management Inc. now owns 2,504,914 shares of the company’s stock valued at $67,256,000 after buying an additional 304,447 shares during the period. Fuller & Thaler Asset Management Inc. increased its stake in shares of Vitamin Shoppe by 20.3% in the second quarter. Fuller & Thaler Asset Management Inc. now owns 1,695,043 shares of the company’s stock valued at $51,817,000 after buying an additional 286,515 shares during the period. GMT Capital Corp bought a new stake in shares of Vitamin Shoppe during the third quarter valued at about $7,586,000. Finally, Citadel Advisors LLC increased its stake in shares of Vitamin Shoppe by 20,677.9% in the third quarter. Citadel Advisors LLC now owns 228,557 shares of the company’s stock valued at $6,137,000 after buying an additional 227,457 shares during the period.

COPYRIGHT VIOLATION WARNING: This news story was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another publication, it was illegally copied and republished in violation of U.S. & international trademark & copyright laws. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2016/11/30/vitamin-shoppe-inc-vsi-receives-consensus-rating-of-hold-from-analysts.html.

Shares of Vitamin Shoppe (NYSE:VSI) traded down 1.1980% during mid-day trading on Wednesday, hitting $24.7499. The company’s stock had a trading volume of 130,630 shares. The company has a 50-day moving average price of $25.85 and a 200-day moving average price of $28.11. The stock has a market cap of $579.91 million, a PE ratio of 14.5931 and a beta of 0.66. Vitamin Shoppe has a 1-year low of $21.90 and a 1-year high of $34.41.

Vitamin Shoppe (NYSE:VSI) last released its earnings results on Wednesday, November 2nd. The company reported $0.50 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.50. The firm earned $314.90 million during the quarter, compared to analysts’ expectations of $317.18 million. Vitamin Shoppe had a return on equity of 11.52% and a net margin of 3.34%. The company’s revenue was up .3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.52 EPS. Analysts predict that Vitamin Shoppe will post $2.14 EPS for the current fiscal year.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.

5 Day Chart for NYSE:VSI

Receive News & Stock Ratings for Vitamin Shoppe Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc. and related stocks with our FREE daily email newsletter.